Search results

Women who have been lucky enough to survive breast cancer may face increased risk of lung cancers, according to a new study in Radiotherapy and Oncology. The study shows how this can be prevented — limiting the radiation dose to a lung, using a treatment which targets only a small part of the breast.
Breast cancer is the most frequently diagnosed cancer in women, with more than 266,000 new cases diagnosed in 2018 in the United States.

Due to the daily coarsening of civil discourse on social media, routine conflict resolution has gone out the window. If that is all kids see, then that is all they learn for their future.

With Americans living longer than ever, more and more attention is being paid to how adults manage potentially-fatal diseases and end-of-life issues. Here are two cases in point, both focusing on the mental – not medicinal – aspects of this topic: a recent book about embracing mortality, and the growing prominence of so-called "cancer coaches."

According to pharmacologist Ray Dingledine, good science is hard to do because of (1) "our drive to create a coherent narrative from new data, regardless of its quality or relevance"; (2) "our inclination to seek patterns in data whether they exist or not"; and (3) our negligence to "always consider how likely a result is regardless of its P-value." The good news is that this can be fixed.

It turns out that tiny phytoplankton, which can cause massive "blooms," may actually affect our weather. As we will see, there's more to climate than just warming.

Just like the hapless victim in Three Card Monte, physicians will bear the brunt of financial risk in Medicare Advantage and other "risk sharing" plans. It is not that they shouldn't have skin in the game, it's just that all the skin should not be theirs.

Did you know if you had a cardiac arrest, the decision to give you a potentially life-saving medication or placebo – in the fleeting moment where seconds matter – might be made at random by those coordinating a study? A little-known FDA exemption allows for it.

A small study of the Thanksgiving cranberry raises the issue of when science in the public interest transitions from informing to advocacy and then to marketing.

The Holiday Season is in full swing, and we here at the American Council on Science and Health continue our fight on behalf of good science! Here's where we appeared in recent days.

Anyone who believes that vaccines cause autism shouldn't be in a position of authority. The fundamental problem with someone making such a claim is not that s/he is wrong. Instead, it reveals someone who's conspiratorially minded and lacks critical thinking skills. That's not the sort of person who should be in charge of anything important.

ProPublica, like a dog with a bone, continues to chew at Memorial Sloan Kettering and what the publication feels is the hospital's conflict of Interest. But it's time to put the bone down and have a more honest discussion. Why is one of the world's greatest hospitals still a ProPublica punching bag?

Everyone believes in evidence-based decision making. But why is it so hard to find the evidence we need?

Fiber is an oft-ignored member of the carbohydrate family. But it provides significant health benefits and with careful selections it tastes good, too.

Oxytocin-deficient animals point to deep links between social behavior and the need to keep warm.

Insurance providers use big sticks. They call them co-payments and high deductibles, used to try and lower their costs. Yet, when they try the carrot of rewards -- using actual dollars -- we have little interest.

Physicians from across the political spectrum and the country, representing nearly every specialty, came to Washington, DC last week. They did so to advocate for patients, spotlighting many hidden ways healthcare dollars are wasted.

If we're not likely to see a significant pull incentive in the United States (or anywhere else) this year, a likely outcome, where can we go next? There are two actions we can take that will help.

Let's consider statins, a medication used by millions of Americans. Before we push to get more patients treated, perhaps we should get the ones already being treated to take their medications properly (if at all).

Digital health is coming, and many services are already coming to a smartphone near you. As the first guidelines from the World Health Organization indicate, the obstacles aren't technological. They're regulatory.

While the federal courts weigh whether CVS-Aetna's merger is anti-competitive, in terms of drug pricing, they are seemingly ignoring CVS's new HealthHubs. A product of the data synergy of a pharmacy and health insurer, those hubs will disrupt healthcare in ways that will shift profits to themselves and costs to society at large. Just they way Big Tobacco or Big Oil did.

When we talk of patient safety, the analogy is often to aviation. But perhaps like commercial flight's problems with baggage, the last little push -- from a very few to never -- is a very steep hurdle.

Binge watching as an African American is detrimental to your health. (But the same can be said for every racial group.) Is there something unique about their physiology that puts them at greater risk? Or is this just a chance to publish what we already know, cloaked in a legitimate concern about disparities in research and outcomes?

Why do patients seek a second opinion? Even when making an "evidence-based" decision, our unconscious bias towards one option or another alters how we judge the evidence -- and how long we search.

For those of us distracted by our phones, there's a new app to help us focus. Should we be surprised? No. A proof of concept study has the details.

Imagine you’re a firefighter trying to prevent a house from burning to the ground. After many hours of hard work you’ve rescued the family, saved their pet chinchilla and extinguished every visible ember — a job well done. Wouldn’t it be strange if the blaze came roaring back the following day?